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Abstract
Background: HIV epidemiology among female sex workers (FSWs) and their clients in the Middle East and North
Africa (MENA) region is poorly understood. We addressed this gap through a comprehensive epidemiological assessment.
Methods: A systematic review of population size estimation and HIV prevalence studies was conducted and reported
following PRISMA guidelines. Risk of bias (ROB) assessments were conducted for all included studies using various quality
domains, as informed by Cochrane Collaboration guidelines. The pooled mean HIV prevalence was estimated using
random-effects meta-analyses. Sources of heterogeneity and temporal trends were identified through meta-regressions.
Results: We identified 270 size estimation studies in FSWs and 42 in clients, and 485 HIV prevalence studies in 287,719
FSWs and 69 in 29,531 clients/proxy populations. Most studies had low ROB in multiple quality domains. The median
proportion of reproductive-age women reporting current/recent sex work was 0.6% (range = 0.2–2.4%) and of men
reporting currently/recently buying sex was 5.7% (range = 0.3–13.8%). HIV prevalence ranged from 0 to 70% in FSWs
(median = 0.1%) and 0–34.6% in clients (median = 0.4%). The regional pooled mean HIV prevalence was 1.4% (95% CI =
1.1–1.8%) in FSWs and 0.4% (95% CI = 0.1–0.7%) in clients. Country-specific pooled prevalence was < 1% in most
countries, 1–5% in North Africa and Somalia, 17.3% in South Sudan, and 17.9% in Djibouti. Meta-regressions identified
strong subregional variations in prevalence. Compared to Eastern MENA, the adjusted odds ratios (AORs) ranged from 0.2
(95% CI = 0.1–0.4) in the Fertile Crescent to 45.4 (95% CI = 24.7–83.7) in the Horn of Africa. There was strong evidence for
increasing prevalence post-2003; the odds increased by 15% per year (AOR = 1.15, 95% CI = 1.09–1.21). There was also a
large variability in sexual and injecting risk behaviors among FSWs within and across countries. Levels of HIV testing
among FSWs were generally low. The median fraction of FSWs that tested for HIV in the past 12 months was 12.1%
(range = 0.9–38.0%).
Conclusions: HIV epidemics among FSWs are emerging in MENA, and some have reached stable endemic levels,
although still some countries have limited epidemic dynamics. The epidemic has been growing for over a decade, with
strong regionalization and heterogeneity. HIV testing levels were far below the service coverage target of “UNAIDS 2016–
2021 Strategy.”
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Background
The Middle East and North Africa (MENA) is one of only
two regions where HIV incidence and AIDS-related mor-
tality are rising [1]. Between 2000 and 2015, the increase
in the number of new infections was estimated at over a
third, while that of AIDS-related deaths, at over threefold
[1–3]. MENA has been described as “a real hole in terms
of HIV/AIDS epidemiological data” [4], with unknown
status and scale of epidemics in multiple countries [5–7].
Despite recent progress in HIV research and surveillance
in MENA [8], including the conduct of integrated bio-
behavioral surveillance surveys (IBBSS) [5, 9], many of these
data are, at best, published in country-level reports, or never
analyzed. Since 2007, the “MENA HIV/AIDS Epidemiology
Synthesis Project” has maintained an active regional HIV
database [6]. The first systematic syntheses of HIV data doc-
umented concentrated and emerging epidemics among
men who have sex with men (MSM) [10] and people who
inject drugs (PWID) [11]. The majority of these epidemics
emerged within the last two decades [10, 11].
Although the size of commercial heterosexual sex net-
works is expected to be much larger than the risk networks
of MSM and PWID [6, 7], estimates for the population
proportion of female sex workers (FSWs), volume of clients
they serve, and geographic and temporal trends in infection
remain to be established. This evidence gap was
highlighted in the latest gap report by the Joint United Na-
tions Programme on HIV/AIDS (UNAIDS) [3], indicating
“a lack of data on the burden of HIV among sex workers in
the region” and stressing that “the epidemic among them is
poorly understood” though “HIV in every country is
expected to disproportionately affect sex workers” [3].
This study characterizes HIV epidemiology among
FSWs and their clients in MENA by (1) systematically
reviewing and synthesizing all available published and un-
published records documenting population size estimates,
population proportions, HIV incidence, and HIV preva-
lence (including in proxy populations of clients such as
male sexually transmitted infection (STI) clinic attendees);
(2) estimating, for each population, the pooled mean HIV
prevalence per country and regionally; (3) identifying the
regional-level associations with prevalence, sources of het-
erogeneity, and temporal trends; and (4) synthesizing the
key measures of sexual and injecting risk behaviors.
Methods
Search strategy and selection criteria
Evidence for population size estimate, population propor-
tion, HIV incidence, and HIV prevalence in FSWs and
clients was systematically reviewed as per Cochrane’s Col-
laboration guidelines [12]. Findings were reported following
the Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) guidelines [13] (checklist in Add-
itional file 1: Table S1). MENA definition here includes 23
countries extending from Pakistan to Morocco (Add-
itional file 1: Figure S1), based on the convention in HIV
research [6, 7, 10, 11] and on World Health Organization
(WHO), UNAIDS, and World Bank definitions [6]. MENA
was also classified by subregion comprising Eastern MENA
(Afghanistan, Iran, Pakistan), the Fertile Crescent (Egypt,
Iraq, Jordan, Lebanon, Palestine, Syria), the Gulf (Bahrain,
Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates,
Yemen), the Horn of Africa (Djibouti, Somalia, recently
independent South Sudan), and North Africa (Algeria,
Libya, Morocco, Sudan, Tunisia).
Systematic searches were performed, up to July 29,
2018, on ten international-, regional-, and country-level
databases; abstract archives of International AIDS Society
conferences [14]; and Synthesis Project database which in-
cludes country-level and international organizations’
reports and routine data reporting [6, 7] (Additional file 1:
Box S1). No language or year restrictions were used.
Titles and abstracts of unique citations were screened for
relevance, and full texts of relevant/potentially relevant
citations were retrieved for further screening. Any docu-
ment/report including outcomes of interest based on pri-
mary data was eligible for inclusion. Case reports, case
series, editorials, commentaries, and studies in populations
(such as “vulnerable women”) where overlap with FSWs is
implied but engagement in sex work is not explicitly indi-
cated were excluded. Reference lists of reviews and all rele-
vant documents were hand searched for eligible reports.
In this article, the term study refers to a specific out-
come measure (population size estimate, incidence, or
prevalence) in a specific population. Therefore, one report
could contribute multiple studies, and one study could be
published in different reports. Duplicate study results were
included only once using the more detailed report.
Data extraction and synthesis
Data extraction was performed by HC and double extrac-
tion by MH, with discrepancies settled by consensus or by
contacting authors. Data were extracted from full texts by
native speakers (extraction list in Additional file 1: Box S2).
Population size estimates and population proportions
were grouped based on being of national coverage or for
specific subnational settings, and distinguishing between
current FSWs/clients and history of sex work/ex-client.
For FSWs, population proportion is defined as the pro-
portion of all reproductive-age women that are engaged
in sex work, that is the exchange of sex for money (sex
work as a profession) [15, 16], and for clients, as the
proportion of men buying sex from FSWs using money.
Studies with mixed or non-representative samples (sam-
ples biased towards oversampling FSWs with no esti-
mate adjustment) were excluded.
Due to the paucity of studies directly looking at HIV
prevalence in clients of FSW, HIV prevalence studies in
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male STI clinic attendees, or mixed-sex samples of pre-
dominantly men (> 60%), were used as a proxy for HIV
prevalence in clients of FSWs [17, 18].
Based on meta-analysis results for the pooled HIV preva-
lence in FSWs, epidemics were classified as concentrated
(prevalence > 5%), intermediate-intensity (prevalence
between 1 and 5%), and low-level (prevalence < 1%), as
informed by epidemiological relevance and existing conven-
tions [19–21].
HIV incidence studies were identified and reported. Add-
itional contextual information was extracted from FSW
studies included in the review. These include age, age at
sexual debut, age at sex work initiation, sex work duration,
marital status, and HIV/AIDS knowledge and perception of
risk, as well as behavioral measures of condom use, inject-
ing drug use, sexual partnerships, and HIV testing.
Data were summarized using medians and ranges.
Quality assessment
Risk of bias (ROB) assessments for population size esti-
mates/population proportions and for HIV prevalence
were conducted as informed by Cochrane Collaboration
guidelines [12] (criteria in Additional file 1: Table S2).
Briefly, size estimation studies were classified as having
“low” versus “high” ROB on each of the three domains
assessing the (1) validity of sex work definition/engagement
in paid sex (clear/valid definition; otherwise), (2) rigor of
estimation methodology (likely-to-yield representative esti-
mate; otherwise), and (3) response rate (≥ 60%; < 60%).
Prevalence studies were similarly classified on each of the
four domains assessing the (1) validity of sex work defin-
ition/engagement in paid sex (clear/valid definition; other-
wise), (2) rigor of sampling methodology (probability-based;
non-probability-based), (3) response rate (≥ 60% or ≥ 60%
of target sample size reached for studies using respondent-
driven or time-location sampling; < 60%), and (4) type of
HIV ascertainment (biological assays; self-report).
Studies with missing information for a specific domain
were classified as having “unclear” ROB for that domain.
Measures only extracted from routine databases were con-
sidered of unknown quality, as original reports were not
available for assessing ROB, and were not included in the
quality assessment. The impact of quality domains on
observed prevalence was examined in meta-regression
(described below).
Meta-analyses
Pooled mean HIV prevalence in FSWs and client popula-
tions were estimated using random-effects meta-analyses,
by country and for the whole region. Variances were stabi-
lized using Freeman-Tukey-type arcsine square-root
transformation [22, 23]. Weighting was performed using
the inverse-variance method [23, 24]. Pooling was per-
formed using Dersimonian-Laird random-effects models
to allow for sampling variation and true heterogeneity [25,
26]. Overall prevalence measures were replaced by their
stratified measures where applicable.
Heterogeneity was assessed using Cochran’s Q statistic to
confirm the existence of heterogeneity, I2 to estimate the
magnitude of between-study variation, and prediction inter-
vals to estimate the 95% interval of distribution of true ef-
fect sizes [26, 27].
Meta-analyses were implemented in R version 3.4.2 [28].
Meta-regression analyses
Random-effects meta-regression analyses were con-
ducted to identify the regional-level associations with
HIV prevalence in FSWs, sources of between-study het-
erogeneity, and temporal trend. Independent variables
considered a priori were country/subregion, FSW popu-
lation type, sample size, median year of data collection,
sampling methodology, response rate, validity of sex
work definition, and HIV ascertainment (details in Add-
itional file 1: Table S3). The same factors (as applicable)
were considered for clients’ meta-regression analyses.
To avoid the exclusion of studies with zero prevalence,
an increment of 0.1 was added to the number of events
in all studies to calculate the log-transformed odds, that
is prevalence/(1 − prevalence), and corresponding vari-
ance [29]. Factors showing strong evidence for an associ-
ation with the odds (p value ≤ 0.10) in univariable
analysis were included in the multivariable analysis.
Meta-regressions were implemented in Stata/SE v.15.1 [30].
Results
Search results and scope of evidence
Figure 1 shows the study selection process. A total of 16,
131 citations were identified through databases. After ex-
cluding duplicates and title and abstract screening, full texts
of 336 unique citations were screened, and 87 reports were
eligible for inclusion. Hand-searching of reference lists of
relevant reports yielded eight additional eligible reports.
Searching US Census Bureau and UNAIDS databases
yielded 173 additional measures. Sixty-three detailed
country-level reports, 11 of which replaced eligible articles,
and 134 additional measures were further identified
through Synthesis Project database. In sum, data from 147
eligible reports and 307 additional measures were included.
These yielded in total 312 size estimation, 6 HIV incidence,
and 554 HIV prevalence measures in FSWs and clients.
Evidence for population size and/or population propor-
tion of FSWs was available for 12 out of 23 MENA coun-
tries (270 studies). Population size/population proportion
of clients was available in 42 studies from 10 countries. All
6 HIV incidence studies were among FSWs. A total of 485
HIV prevalence studies were identified in 287,719 FSWs
from 17 countries and 69 HIV prevalence studies in 29,531
clients (or proxy populations) from 10 countries. Prevalence
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measures in FSWs and clients contributed respectively 674
and 147 stratified measures for the meta-analyses (overall
prevalence measures were replaced by their strata in meta-
analyses). For all types of measures, there was a high het-
erogeneity in data availability across countries.
Population size estimates and population proportions of
FSWs and clients
Table 1 and Additional file 1: Table S4 show the popula-
tion size estimate and population proportion studies for
FSWs and clients at the national and subnational levels,
respectively. At the national level, the median number of
current/recent FSWs (engaged in sex work in the past
year) was 58,934 (range = 2218 in Djibouti to 167,501 in
Pakistan), and the median population proportion (out of
reproductive-age women aged 15–49 years) was 0.6%
(range across studies = 0.2% in Egypt to 2.4% in Iran). The
median population proportion of current/recent clients
(buying sex from FSWs in the past year) based on diverse
samples of general population men was 5.7% (range across
studies = 0.3% in Sudan to 13.8% in Lebanon).
With high heterogeneity in estimation methodology, time
frame, and scope between and within countries, it was
deemed not meaningful to generate country-specific or re-
gional-pooled estimates for the size/population proportions.
HIV incidence overview
There were six incidence studies among FSWs (three
from each of Somalia and Djibouti; data not shown).
Three studies reported zero seroconversions [51, 52].
Fig. 1 Flow chart of the study selection process in the systematic review following PRISMA guidelines [13]
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One study from Somalia reported a cumulative inci-
dence of 2.6% after 6 months of follow-up [51]. The
other two from Djibouti—among predominantly Ethiop-
ian FSWs (91%)—reported a cumulative incidence of
3.4% [51] and 11.6% [51] after 3 and 9 months of follow-
up, respectively. All incidence studies were conducted
before the year 2000 and were limited in scale and
scope.
HIV prevalence overview
HIV prevalence in FSWs ranged from 0 to 70%, with a
median of 0.1% (Tables 2 and 3 and Additional file 1:
Table S5). There was a high heterogeneity, with almost
half of the studies (46.8%) reporting zero prevalence.
The median prevalence was 0% (range = 0–14%), 2.0%
(range = 0–47.1%), and 18.8% (range = 0–70%) in coun-
tries with low-level (prevalence < 1%), intermediate-
intensity (prevalence 1–5%), and concentrated epidemics
(prevalence > 5%), respectively (epidemic classification
based on the results of meta-analyses; see below and
Table 5). Ranges indicated pockets of higher HIV preva-
lence, even in countries with low-level and intermediate-
intensity epidemics.
In clients/male STI clinic attendees, HIV prevalence
ranged from 0 to 34.6%, with a median of 0.4% (Table 4)
. Studies also showed high heterogeneity with 37.7%
reporting zero prevalence. The median prevalence was
0% (range = 0–1.1%), 0.6% (range = 0–9.6%), and 7.4%
(range = 0.8–34.6%) in countries with low-level,
intermediate-intensity, and concentrated epidemics, re-
spectively. Ranges indicated pockets of higher HIV
prevalence in countries with intermediate-intensity
epidemics.
Quality assessment
Additional file 1: Tables S6-S9 show the summarized
and study-specific quality assessments for the size esti-
mation and HIV prevalence studies in FSWs and clients.
Almost all size estimation studies used clear/valid sex
work definitions, and > 70% used rigorous size estima-
tion methodologies. Similarly, > 70% of prevalence stud-
ies in FSWs used clear/valid sex work definitions and
probability-based sampling for participants’ recruitment.
Meanwhile, > 85% of prevalence studies in clients used
convenience sampling.
Overall, studies were of reasonable quality. The major-
ity of size estimation studies in FSWs and clients had
low ROB on ≥ 2 quality domains (94.4% and 82.1%, re-
spectively), and none had high ROB on ≥ 2 domains.
Similarly, 85.0% of prevalence studies in FSWs and
39.4% of studies in clients had low ROB on ≥ 2 domains
(studies among STI clinic attendees mostly used con-
venience sampling, and few reported on contact with
FSWs), while 0.7% and 6.1% had high ROB on ≥ 2 do-
mains, respectively.
Pooled mean HIV prevalence
The pooled mean HIV prevalence for the MENA region
was 1.4% (95% confidence interval (CI) = 1.1–1.8%) in
FSWs and 0.4% (95% CI = 0.1–0.7%) in clients (Table 5).
A difference was observed between the median preva-
lence and the pooled mean prevalence due to the high
clustering of prevalence measures close to zero.
In FSWs, the national-level pooled mean prevalence
was 0 or < 1% in most countries (low-level epidemics);
between 1 and 5% (intermediate-intensity epidemics) in
Algeria, Libya, Morocco, Somalia, and Sudan; and > 5%
(concentrated epidemics) in Djibouti (17.9%, 95% CI =
13.6–22.6%) and South Sudan (17.3%, 95% CI = 8.7–
28.1%).
In clients/male STI clinic attendees, the national-level
pooled mean prevalence was mostly 0 or < 1%. However,
high prevalence was estimated in Djibouti (5.4%, 95% CI
= 1.5–10.8%) and South Sudan (13.5%, 95% CI = 4.5–
28.8%).
There was evidence for the heterogeneity in effect size
(prevalence) in meta-analyses. p value for Cochran’s Q
statistic was mostly < 0.0001, prediction intervals were
wide, and I2 was often > 50% indicating that most
between-study variability is due to the true differences in
prevalence across studies rather than chance.
Associations with prevalence, sources of between-study
heterogeneity, and temporal trend
Univariable meta-regressions for FSWs demonstrated
strong evidence for an association with odds for sub-
region, population type, sample size, year of data collec-
tion, and response rate (Table 6). Meanwhile, there was
poor evidence for an association with sampling method-
ology, validity of sex work definition, and HIV ascertain-
ment, which were hence dismissed from inclusion in the
multivariable model. Most variability in odds was ex-
plained by subregion (adjusted R2 = 39.8%).
Multivariable analysis indicated strong subregional dif-
ferences and explained 49.2% of the variation (Table 6).
Compared to Eastern MENA, the adjusted odds ratio
(AOR) ranged from 0.2 (95% CI = 0.1–0.4) for the Fer-
tile Crescent to 45.4 (95% CI = 24.7–83.7) for the Horn
of Africa. Studies with a larger sample size (≥ 100)
showed lower odds (AOR = 0.4, 95% CI = 0.2–0.6).
Compared with studies with data collection pre-1993,
studies conducted after 2003 showed strong evidence for
higher odds (AOR = 2.0, 95% CI = 1.2–3.3). Notably, the
trend of increasing odds was evident only after control-
ling for the strong confounding effect of the subregion.
The trend for each subregion was also overall increasing,
though the strength of evidence varied across subregions
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not shown). Including the year of data collection as a
linear term, instead of a categorical variable, using only
post-2003 data indicated strong evidence for increasing
HIV odds (AOR = 1.15, 95% CI = 1.09–1.21, p < 0.0001;
not shown). No association was found with the popula-
tion type or response rate.
Meta-regression analyses for clients demonstrated
similar results to those of FSWs, but with wider CIs con-
sidering the smaller number of prevalence studies (Add-
itional file 1: Table S10). There was evidence that
subregion was associated with HIV odds in clients, but
no evidence that sample size or year of data collection
explained the between-study heterogeneity.
Sex work context and sexual and injecting risk behaviors
For the detailed sex work context and behavioral mea-
sures, we provide here (for brevity) only a high-level
summary of key measures.
Sex work context
Across studies, the mean age of FSWs ranged from 19.5 to
37.4, with a median of 27.8 years. Mean age at sexual debut
ranged from 14.0 to 22.5 years (median = 17.5), and mean
age at sex work initiation ranged from 17.5 to 27.5 years
(median = 22.7). Mean duration of sex work ranged from
0.7 to 14.3 years (median = 5.5). A median of 28.0% (range
= 0.9–76.6%) of FSWs were single, 30.1% (range = 0–
65.5%) were divorced, and 7.0% (range = 0–27.2%) were
widowed.
Reported condom use
There was high heterogeneity in reported condom use
among FSWs by sexual partnership type and across and
within countries (Additional file 1: Table S11). Condom
use at last sex with clients ranged from 1.2 to 94.8%
(median = 44.0%). Consistent condom use with clients
ranged from 0 to 95.2% (median = 26.3%) among all
FSWs and from 38.2 to 45.3% (median = 42.3%) among
FSWs reporting condom use with clients.
Median condom use at last sex with regular clients was
55.9% (range = 25.5–92.0%) and that with one-time clients
was 58.3% (range = 28.5–96.0%). Less condom use at last
sex was found with non-paying partners (median = 22.0%,
range = 4.9–78.3%). There was also variability in condom
use at last anal sex (range = 0–86.5%), though low levels
were generally reported (median = 18.5%).
The median fraction of FSWs who reported having a
condom at the time of study interview was 12.5% (range =
0–66.1%).
Clients and partners
Studies varied immensely in types of measures reporting
data on clients and partners. Some reported a mean num-
ber of regular/non-regular clients, but over various time
frames. Others reported different distributions for the
number of clients (and by client type), also over various
time frames. Summarizing the evidence was therefore
challenging, given the large type of measure variability.
This being said, the mean number of clients in the past
month ranged from 4.4 to 114.0, with a median of 34.0 cli-
ents. Median fraction of FSWs reporting (during the past
month) < 5 clients, 5–9 clients, and 10+ clients was
28.5%, 28.1%, and 19.1%, respectively. FSWs were equally
likely to report regular and one-time clients during the
past month (medians = 80.0% and 81.0%, ranges = 54.3–
92.4% and 59.2–97.5%, respectively).
FSWs reported a distribution of sex acts in the past
week, with a median of 41.2% reporting 1–2 acts, 32.0%
reporting 3–4 acts, and 12.9% reporting 5+ acts. Anal
sex with clients in the past month was reported by a me-
dian of 8.0% (range = 2.3–100%).
Median fraction of FSWs that are married/cohabiting
was 45.3% (range = 0–99.6%), while that of FSWs report-
ing non-paying partners was 48.5% (range = 6.8–86.2%).
The mean number of non-paying partners in the past
month ranged between 1 and 3, with about two thirds
reporting only one partner.
Only few studies investigated group sex: 7.7% [90] of
FSWs reported ever engaging in group sex, 6.2% [68] and
12.9% [68] reported group sex in the past month, and
10.0% [58] in the past week.
Injecting risk behavior, sex with PWID, and substance use
There was a large variability in injecting risk behavior
and substance use among FSWs, but the highest levels
of injecting drug use were reported in Iran and Pakistan
(Additional file 1: Table S12). Median of current/recent
injecting drug use was 2.1% (range = 0–26.6%), but the
majority of studies were from Pakistan. Studies in Iran
reported a history of injecting drug use in the range of
6.1–18.0% (median of 13.6%) among all FSWs and range
of 16.4–25.5% (median of 22.3%) among only ever/active
drug users. A history of injecting drug use was reported
by < 1% (median) of all FSWs (range = 0%–11.8%) in the
rest of MENA countries.
Fraction of FSWs reporting current/recent sex with
PWID ranged from 0.5 to 13.6% within Afghanistan and
0–54.9% within Pakistan, with medians of 5.2% and
5.6%, respectively. Sex with PWID was reported at 23.6%
[93] among FSWs in Iran.
Close to a third of FSWs reported ever using drugs
(median = 27.0%, range = 1.7–90.7%). A median of
8.9% reported current/recent drug use (range = 0.6–
59.0%). Any substance use before/during sex was re-
ported by 37.8% (median, range = 1.0–88.1%). Alcohol
use before/during sex was reported by 44.1% (median,
range = 3.0–70.7%).
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Knowledge of HIV/AIDS and perception of risk
Knowledge of HIV/AIDS was generally high among FSWs
across MENA (Additional file 1: Table S13). Vast majority
of FSWs ever heard of HIV (median = 81.9%, range =
25.4–100%) and were aware of sexual (median = 72.0%,
range = 50.8–94.9%) and injecting (median = 88.7%, range
= 11.5–99.6%) modes of transmission, but to a lesser extent
of condoms as a prevention method (median = 51.6%,
range = 14.1–89.8%)—condoms were more perceived as a
contraception method. Levels of knowledge, however,
varied often substantially within the same country.
Overall, FSWs did not perceive themselves at high risk
of HIV acquisition (Additional file 1: Table S14). Percep-
tion of HIV risk was reported as at-risk (median = 34.6%,
range = 22.8–48.5), low-risk (median = 18.3%, range =
7.1–46.9), medium-risk (median = 16.4%, range = 5.3–
36.1), and high-risk (median = 14.4%, range = 5.9–32.0).
HIV testing
HIV testing among FSWs varied across countries, but
was generally low, with a median fraction of 17.6%
(range = 4.0–99.4%) ever tested for HIV (Additional file 1:
Table S15). Only a median of 12.1% (range = 0.9–38.0%)
of all FSWs tested for HIV in the past 12 months, and
nearly two thirds of those who ever tested did so in the
past 12 months (median = 59.2%, range = 33.3–82.0%).
Majority of FSWs who ever tested were aware of their
status (median = 91.9%, range = 60.0–99.0%).
Discussion
Through an extensive, systematic, and comprehensive as-
sessment of HIV epidemiology among FSWs and clients,
including data presented in the scientific literature for the
first time, we found that HIV epidemics among FSWs
have already emerged in MENA, and some appear to have
reached their peak. Based on a synthesis and triangulation
of evidence from studies on a total of 300,000 FSWs and
30,000 clients, a strong regionalization of epidemics has
been identified. In Djibouti and South Sudan, the HIV
epidemic is concentrated with a prevalence of ~ 20% in
FSWs. In Algeria, Libya, Morocco, Somalia, and Sudan,
the epidemic is of intermediate-intensity (prevalence 1–
5%). Strikingly, in the remaining countries with available
data, the prevalence is < 1%, and most often zero.
A key finding is that HIV prevalence in FSWs has been
(overall) growing steadily since 2003. This is the same
time in which independent evidence has identified the
emergence of major epidemics among both PWID [11]
and MSM [10] in MENA. It is probable that the epidemics
among these key populations have been bridged to FSWs.
An example is Pakistan, where the prevalence among
FSWs was < 1% in almost all cities in three consecutive
IBBSS rounds between 2005 and 2012 [38, 40, 69]. How-
ever, prevalence ranging from 1.5 to 8.8% was
documented in half of the cities in the latest round in
2016–2017 [42]. These emerging epidemics among FSWs
were preceded by large and growing epidemics first
among PWID [11] and then among MSM [10, 11].
Some of the FSW epidemics, particularly those in
Djibouti and South Sudan, emerged much earlier, most
likely by late 1980s [6], mainly affected by geographic
proximity and stronger population links to sub-Saharan
Africa (SSA) [6]. Djibouti is a port country and the
major trade route for Ethiopia and a station for large
international military bases [6, 151]. The majority of
FSWs operating in Djibouti are Ethiopians catering to
the Ethiopian truck drivers transporting shipments from
the Djibouti port [84–86]. South Sudan is socio-
culturally part of SSA, with a major fraction of FSWs
coming from Uganda, Congo, and Kenya [79]. In these
MENA countries, HIV in commercial heterosexual sex
networks (CHSNs) is well-established and epidemics are
concentrated—though at levels lower than the hyper-
endemic epidemics observed in SSA [152].
Unlike the epidemics among PWID and MSM [10, 11],
the FSW epidemics have been overall growing rather
slowly, with the prevalence being mostly < 5%. Strikingly,
a considerable fraction of countries still do not appear to
have much HIV transmission in CHSNs, with consistently
very low prevalence, quite often even at zero level—46.8%
of studies in FSWs reported zero prevalence, and 7 out of
18 countries had a pooled mean prevalence of zero or
nearly zero. One explanation for the observed low HIV
prevalence could be that HIV has not yet been effectively
introduced into CHSNs—it took decades for HIV to be ef-
fectively introduced into PWID [11] and MSM [10]
networks. Another possible factor pertains to the structure
of CHSNs, characterized apparently by low connectivity
[6, 153, 154], which reduces the risk of HIV being intro-
duced, or efficiently/sustainably transmitted. Unlike PWID
and MSM, FSWs are also exposed to HIV mainly through
their clients, who have a lower risk of exposure to HIV
than themselves, thus possibly contributing to slower
epidemic growth [6].
Other factors may also contribute to explaining the
observed low HIV prevalence. The synthesized evidence
suggests a lower risk environment for FSWs in MENA,
compared to other regions. The reported number of
clients is rather low at a median of 34 per month, at the
lower end of global range [155–158]. Close to half of
commercial sex acts are protected through condom use,
with no difference between regular and one-time clients,
despite noted variability across and within countries.
HIV/AIDS knowledge also varies, but is generally sub-
stantial, with the majority of FSWs being aware of sexual
and injecting modes of transmission, and over half are
aware of condoms as a prevention method. Injecting
drug use and sex with PWID is low in most countries,
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except for countries in Eastern MENA, notably
Afghanistan, Iran, and Pakistan. Serological markers for
hepatitis C virus (a marker of injecting risk) [159–161] are
also low in FSWs, assessed at a median of 1.1% (range = 0–
9.9%, not shown), with the highest measures reported in
Iran [61, 162]. These relatively lower levels of risk behavior
than other regions [163–165] stand in contrast to what has
been observed in PWID and MSM in MENA [10, 11].
Importantly, with the efficacy of 60% in randomized
clinical trials [166–169], male circumcision, which is es-
sentially at universal coverage across MENA [170], may
have also slowed, or even substantially reduced HIV
transmission in CHSNs leading to the observed low HIV
prevalence [171]. Incidentally, the two most affected
countries—South Sudan and Djibouti—are nearly the
only two major settings where male circumcision is at
low coverage in MENA, either nationally, as is the case
for South Sudan [170], or among clients of FSWs, as is
the case for Ethiopian truckers and international military
personnel stationed in Djibouti [151, 170]. Though HIV
prevalence will probably continue to increase among
FSWs and clients, the high levels of male circumcision
coupled with lower levels of risk behavior may prevent
significant epidemics, as seen elsewhere [172–174], from
materializing in CHSNs in multiple MENA countries.
HIV prevalence in FSWs in few countries, particularly in
Eastern MENA, may not necessarily reflect heterosexual as
much as iatrogenic exposures through injecting drug use.
Specifically, in Iran and Pakistan, countries with large HIV
epidemics among PWID [11], a considerable fraction of
FSWs report current/recent/history (14% in Iran and 2% in
Pakistan) of injecting drug use. High prevalence of sex work
is also reported in women engaging in injecting drug use
[93, 175, 176]. Current/recent/history of sex with PWID is
also common (24% in Iran and 6% in Pakistan). The overlap
between these key populations suggests a potential for HIV
to be bridged from PWID networks to CHSNs, as seem to
have occurred in Pakistan recently [42, 177, 178].
Population proportion of current/recent FSWs ranged
from 0.2 to 2.4% across studies with a median of 0.6%,
while that of current/recent clients ranged from 0.3 to
13.8% with a median of 5.7%, both on the lower end of
global range [179, 180]. Though these population pro-
portions may seem small, the size of CHSNs is much lar-
ger than that of PWID and MSM [10, 11, 181]. This
suggests that CHSNs could be a main driver of HIV inci-
dence in many countries despite the low HIV prevalence
in FSWs. An example is Morocco where the mode of
transmission analyses estimated that over half of HIV in-
cidence is driven by CHSNs, despite an HIV prevalence
of only ~ 2% in FSWs [182–184]. The role of CHSNs is
even more significant in countries with concentrated ep-
idemics. In Djibouti, for example, the large HIV epi-
demic among FSWs was mirrored shortly after by a
rapid rise in prevalence among clients (as proxied by
male STI clinic attendees; Table 4), leading eventually to
a prevalence > 1% in pregnant women [6].
HIV response to the epidemic in CHSNs in MENA con-
tinues to be weak and limited in scope and scale [185].
Criminality [151, 185] and stigma [186–188] associated
with sex work persist as barriers to surveillance and tar-
geted programming [189–191], leading even to the resist-
ance to acknowledge the existence of sex work [192].
These challenges are compounded by the diverse typolo-
gies and increased mobility of FSWs [41, 70, 151]. Across
MENA, only 18% of FSWs reported ever testing for HIV,
and fewer (12%) reported testing in the past 12 months,
far below the 90% service coverage target of “UNAIDS
2016–2021 Strategy” [193]. Programs, including health-
care provision, where they exist, are nearly always imple-
mented by non-governmental organizations (NGOs), who
often lack the resources or legal coverage to deliver com-
prehensive prevention interventions [6, 185].
There are, however, notable exceptions. Morocco has
established an evidence-informed national strategy and
rapidly scaled up provision of comprehensive services for
at-risk populations, including outreach peer education
programs as well as testing and case management services
[183, 185]. Voluntary counseling and testing centers were
established nationwide, with FSWs estimated to constitute
about a quarter of attendees in 2007 [183, 194]. Findings
of the 2011–2012 IBBSS indicated that over a third of
FSWs ever tested for HIV, the vast majority of whom were
aware of their status [67]. Condom use at last sex also in-
creased from 37% in 2003 to a median of 50% in 2011
(Additional file 1: Table S11). Morocco’s success has been
grounded on a strong multisectorial response where
NGOs, in partnership with the government, play a leading
role in implementing interventions [185]. In Iran, the large
expansion of harm reduction services, including the first
women-operated services in MENA [11], is a promising
step for targeting FSWs most at risk.
This study is limited by gaps in evidence. Epidemic status
among FSWs remains unknown in six countries, as no data
were identified. Others (Bahrain and Libya) also had lim-
ited data to warrant a meaningful characterization of the
epidemic. The high heterogeneity of epidemics within
countries suggests that caution is needed when interpreting
data without a representative national coverage. For in-
stance, while concentrated epidemics among FSWs are
documented in southern Morocco [67, 195] and southern
Algeria [113, 196–198], these do not appear to be represen-
tative of FSWs at the national level [42, 67, 74, 78, 81, 82,
113, 195–199]. Hidden epidemics or outbreaks may also
exist in specific geographies within the country, but not ne-
cessarily elsewhere. Data varied over time with high quality
and volume of evidence available mostly post-2000, thanks
to the expansion and funding of IBBSS studies. While the
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pooled prevalence estimates were meant to provide a
summary of the relative standing of MENA countries in
the HIV epidemic, the large between-study heterogeneity
suggests that caution is warranted when interpreting these
estimates. Studies in clients of FSWs/proxy populations re-
main limited with wide variability in evidence availability
across MENA.
A considerable fraction of studies used convenience
sampling, although meta-regression indicated no differ-
ence in the prevalence by sampling methodology. This
may be explained by FSWs being more “visible” [151,
200] compared to PWID [11] and MSM [10]. A sizable
fraction of studies was from routine data reporting with
no sufficient documentation of study methodology.
However, most of these country-level program data were
presumably based on rigorous case definitions following
WHO guidelines [6]. There is also a possibility that a
fraction of studies may have enrolled women without a
strict and valid definition for sex work, yet meta-
regression findings showed no effect for the validity of
sex work definition on HIV prevalence. There was also
no evidence that other study-specific quality domains,
including HIV ascertainment method and response rate,
had an effect on prevalence. A considerable fraction of
studies reported zero prevalence, thus an increment of
0.1 was added to a number of events to be able to con-
duct the meta-regressions. While this choice of incre-
ment was arbitrary, other increments yielded the same
findings, though some of the effect sizes changed in
scale. There was evidence for a small-study effect in
meta-regression suggesting potential publication bias to-
wards studies reporting higher prevalence.
Conclusions
HIV epidemics among FSWs are emerging in MENA, with
some already established. The epidemic has been growing
steadily in recent years, with strong regionalization and
heterogeneity. A contributing factor to epidemic growth
appears to be the epidemics that emerged among PWID
[11] and MSM [10] nearly two decades ago. Strikingly, a
large fraction of countries still do not appear to have any
significant epidemic dynamics in CHSNs. These findings
demonstrate the need for expanding surveillance systems,
including the conduct of repeated IBBSS studies with na-
tional coverage to monitor HIV prevalence trends and to
detect the emergence of epidemics. There is also a pressing
need for mapping and size estimation studies to delin-
eate the diverse typologies of sex work and to ensure
evidence-informed response with adequate coverage of
interventions.
Achieving “UNAIDS 2016–2021 Strategy” [193] ser-
vice coverage targets entails reaching out to the increas-
ingly dispersed FSW population [41, 70, 151]. Building
on Morocco’s success, this would be best achieved
through NGOs leading the provision of comprehen-
sive interventions, with governmental support, even if
discrete. Extending harm reduction services to women
PWID is also critical to curb HIV burden in FSWs
most at risk, specifically in Eastern MENA. The win-
dow of opportunity for detecting epidemics at their
nascence, and for controlling incidence in CHSNs,
should not be missed.
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